$0.00
(0.00%
) Quote detailsUSD
$0.00
(0.00%
)At Close (As of Dec 15, 2025)
$148.66M
Market Cap
-
P/E Ratio
-1.46
EPS
$14.47
52 Week High
$7.78
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Greenwich LifeSciences, Inc. is a clinical-stage biopharmaceutical firm based in Stafford, Texas, focused on developing innovative immunotherapies for cancer treatment, particularly targeting HER2/neu-expressing tumors, such as breast cancer. The company's lead candidate, GP2, is designed to bolster the immune response against cancer cells, addressing critical unmet needs in oncology. With a robust pipeline of therapies and a commitment to advancing cancer care, Greenwich LifeSciences is strategically positioned to make meaningful contributions to patient outcomes in an evolving therapeutic landscape.
LPTX
WOK
MASK
NVDA
TSLA
ASST
IRBT
CGC
PLUG
AAL
ASBP
AVGO
IVP
PFE
LAZR
INTC
BITF
GRAB
BYND
F
WBD
ADAP
SOFI
CIFR
ARTV
IREN
KVUE
CLSK
MARA
PLTD
ORCL
APLD
SNAP
DNN
TLRY
NFLX
T
WULF
BTBT
RGTI
RKLB
VZ
PLTR
BAC
UBER
NIO
RIG
HPE
AMC
DVLT
QBTS
GOOGL
HOOD
SOUN
CAN
AMD
MU
PCG
MSTR
RR
HBAN
MSFT
CPNG
VALE
CMG
CLYM
KDP
IONQ
NCLH
LPTX
WOK
MASK
NVDA
TSLA
ASST
IRBT
CGC
PLUG
AAL
ASBP
AVGO
IVP
PFE
LAZR
INTC
BITF
GRAB
BYND
F
WBD
ADAP
SOFI
CIFR
ARTV
IREN
KVUE
CLSK
MARA
PLTD
ORCL
APLD
SNAP
DNN
TLRY
NFLX
T
WULF
BTBT
RGTI
RKLB
VZ
PLTR
BAC
UBER
NIO
RIG
HPE
AMC
DVLT
QBTS
GOOGL
HOOD
SOUN
CAN
AMD
MU
PCG
MSTR
RR
HBAN
MSFT
CPNG
VALE
CMG
CLYM
KDP
IONQ
NCLH